Zepbound: The New FDA-Approved Weight Management Solution
Автор: Druglly
Загружено: 2024-02-06
Просмотров: 53
Описание:
The U.S. Food and Drug Administration (FDA) has recently approved Zepbound (tirzepatide) injection for chronic weight management in adults with obesity (body mass index of 30 kg/m2 or greater) or overweight (body mass index of 27 kg/m2 or greater) with at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol.
This approval allows the use of Zepbound in addition to a reduced calorie diet and increased physical activity. Tirzepatide, the active ingredient in Zepbound, is already approved under the trade name Mounjaro to help improve blood sugar (glucose) in adults with type 2 diabetes mellitus when used along with diet and exercise.
This approval provides a new treatment option for individuals struggling with obesity or overweight and its associated health conditions. It is important to note that the use of Zepbound should be accompanied by a reduced calorie diet and increased physical activity to achieve the best results. The FDA's decision was based on clinical trials that demonstrated the effectiveness of tirzepatide in promoting weight loss and addressing weight-related conditions in the target population.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
